MEF2C and acute lymphoblastic leukemia: In our study, we found that this patient with MEF2C::SS18L1 fusion also showed: (1) high expression of HDAC9, (2) deletion of CD10 and (3) high expression of CD38. Coincidentally, this is consistent with the performance of MEF2D::SS18 fusion positive ALL.